Logo Lanfrica

Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Yaoundé, Cameroon From 2009 to 2014

Domaine:

healthcare
Créateur:
CarMAG
Éditeur:
Ovi
Hôte:
Abstract We investigated the antimicrobial resistance in gonococci 2009 to 2014 in Yaoundé, Cameroon, and recommend revisions of the Cameroonian treatment guideline. We observed a high resistance to ciprofloxacin (17.6%) but no ceftriaxone resistance. Ceftriaxone should replace ciprofloxacin as the recommended first-line treatment for urethral/vaginal discharge. Enhanced resistance surveillance in Africa is essential.

Similaires

Phenotypic and genotypic characterization of Neisseria gonorrhoeae isolates from Yaoundé, Cameroon, 2019 to 2020

This study investigated antimicrobial resistance (AMR) phenotypes and genotypes exhibited by

Comparison of endocervical swabs to cultured isolates for the detection of antimicrobial resistance determinants in Neisseria gonorrhoeae

Background: The global emergence of antimicrobial resistance (AMR) in Neisseria gonorrhoeae to vario

Prevalence and Antimicrobial Susceptibility Pattern of Neisseria Gonorrhoeae from Selected Public Health Centers, Addis Ababa, Ethiopia.

Abstract Background : Neisseria gonorrhea (NG) is gram negative diplococcic bacteria th

Antimicrobial Resistance Profiling and Phylogenetic Analysis of Neisseria gonorrhoeae Clinical Isolates From Kenya in a Resource-Limited Setting

Background Africa has one of the highest incidences of

High-Resolution Melting Analysis to Detect Antimicrobial Resistance Determinants in South African Neisseria gonorrhoeae Clinical Isolates and Specimens

Background. Antimicrobial resistance is limiting treatment options for Neisseria gonorrhoeae infecti

Antimicrobial resistance profiling and phylogenetic analysis of <i>Neisseria gonorrhoeae</i> clinical isolates from Kenya in a resource-limited setting

Abstract Background A